Michael C. Latham

TL;DR: Rationales and evidence are presented to justify ensuring the widest possible coverage for preschool-age children and girls and women of childbearing age in intestinal parasite control programmes, in order to prevent morbidity and mortality in general and specifically to help decrease the vicious intergenerational cycle of growth failure.

TL;DR: It is concluded that single-dose treatment with albendazole can allow improved physical fitness, growth, and appetite in school-age children in areas where these helminths and poor growth are highly prevalent.

TL;DR: A randomized, double-blind, placebo-controlled trial was conducted in Kenya to examine the effect of iron supplements on appetite and growth in 87 primary school children as mentioned in this paper, where Sustained-release ferrous sulfate (150 mg) or placebo tablets were provided daily at school for 14 wk.

TL;DR: It is shown that single dose treatment with albendazole, despite continual exposure to infection, can permit improved growth rates in areas where intestinal helminths and protein-energy malnutrition are highly prevalent.

TL;DR: It is concluded that one or two doses of albendazole per year resulted in similar growth improvements, despite reinfection, in school-age children in an area where these helminths and poor growth are prevalent.